开云app官网登录入口网页版-官方正版

#Antiviral#

8篇内容 | 959人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1634969, encodeId=eade163496921, content=<a href='/topic/show?id=4cea2604a9' target=_blank style='color:#2F92EE;'>#Antiviral#</a>, objectTitle=Antiviral Res：寨卡病毒基因工程疫苗研究新进展, objectType=article, longId=137034, objectId=836a13e034f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=836a13e034f3, replyNumber=0, likeNumber=62, createdTime=2018-11-13, rootId=0, userName=1249857fm39暂无昵称, userId=79b222353111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=836a13e034f3, moduleTitle=Antiviral Res：寨卡病毒基因工程疫苗研究新进展, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=836a13e034f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634967, encodeId=686c163496e26, content=<a href='/topic/show?id=4cea2604a9' target=_blank style='color:#2F92EE;'>#Antiviral#</a>, objectTitle=Antiviral Res：我国在单纯疱疹病毒中和抗体的研究中取得重要进展, objectType=article, longId=118664, objectId=b0ef11866487, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0ef11866487, replyNumber=0, likeNumber=63, createdTime=2017-12-12, rootId=0, userName=1249857fm39暂无昵称, userId=79b222353111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0ef11866487, moduleTitle=Antiviral Res：我国在单纯疱疹病毒中和抗体的研究中取得重要进展, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b0ef11866487)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634968, encodeId=b1ab163496847, content=<a href='/topic/show?id=4cea2604a9' target=_blank style='color:#2F92EE;'>#Antiviral#</a>, objectTitle=Antiviral Res：欧洲和欧亚国家的丙肝诊断和治疗的可用性, objectType=article, longId=123236, objectId=788412323622, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=788412323622, replyNumber=0, likeNumber=57, createdTime=2018-08-01, rootId=0, userName=1249857fm39暂无昵称, userId=79b222353111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=788412323622, moduleTitle=Antiviral Res：欧洲和欧亚国家的丙肝诊断和治疗的可用性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=788412323622)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634966, encodeId=43fd16349666c, content=<a href='/topic/show?id=4cea2604a9' target=_blank style='color:#2F92EE;'>#Antiviral#</a>, objectTitle=Antiviral Res：在哺乳动物和植物细胞中产生的一个新的嵌合的HBV S/preS1抗原会引起比标准的疫苗成分S蛋白质更强的体液和细胞免疫反应, objectType=article, longId=104502, objectId=60b4104502a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60b4104502a5, replyNumber=0, likeNumber=58, createdTime=2017-10-06, rootId=0, userName=1249857fm39暂无昵称, userId=79b222353111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60b4104502a5, moduleTitle=Antiviral Res：在哺乳动物和植物细胞中产生的一个新的嵌合的HBV S/preS1抗原会引起比标准的疫苗成分S蛋白质更强的体液和细胞免疫反应, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=60b4104502a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634965, encodeId=bd64163496540, content=<a href='/topic/show?id=4cea2604a9' target=_blank style='color:#2F92EE;'>#Antiviral#</a>, objectTitle=Antiviral Res：中山大学曹永长教授研究团队发表H7N9流感病毒广谱疫苗研究进展, objectType=article, longId=97076, objectId=b6fd9e07621, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6fd9e07621, replyNumber=0, likeNumber=121, createdTime=2017-12-16, rootId=0, userName=1249857fm39暂无昵称, userId=79b222353111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6fd9e07621, moduleTitle=Antiviral Res：中山大学曹永长教授研究团队发表H7N9流感病毒广谱疫苗研究进展, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b6fd9e07621)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634963, encodeId=3d951634963b8, content=<a href='/topic/show?id=4cea2604a9' target=_blank style='color:#2F92EE;'>#Antiviral#</a>, objectTitle=Antiviral Res：T-705抑制剂可成功治疗早期埃博拉病毒感染, objectType=article, longId=43035, objectId=1f9e4303574, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f9e4303574, replyNumber=0, likeNumber=78, createdTime=2015-10-16, rootId=0, userName=1249857fm39暂无昵称, userId=79b222353111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f9e4303574, moduleTitle=Antiviral Res：T-705抑制剂可成功治疗早期埃博拉病毒感染, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1f9e4303574)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634964, encodeId=98e516349648d, content=<a href='/topic/show?id=4cea2604a9' target=_blank style='color:#2F92EE;'>#Antiviral#</a>, objectTitle=Antiviral Res：拉沙热研究新机遇, objectType=article, longId=44832, objectId=516c4483239, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=516c4483239, replyNumber=0, likeNumber=51, createdTime=2015-02-23, rootId=0, userName=1249857fm39暂无昵称, userId=79b222353111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=516c4483239, moduleTitle=Antiviral Res：拉沙热研究新机遇, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=516c4483239)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634962, encodeId=97e8163496232, content=<a href='/topic/show?id=4cea2604a9' target=_blank style='color:#2F92EE;'>#Antiviral#</a>, objectTitle=Antiviral Res：王建华等III型干扰素IFNλ抗HIV-1研究获进展, objectType=article, longId=6531, objectId=246165310a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=246165310a, replyNumber=0, likeNumber=62, createdTime=2012-07-22, rootId=0, userName=1249857fm39暂无昵称, userId=79b222353111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=246165310a, moduleTitle=Antiviral Res：王建华等III型干扰素IFNλ抗HIV-1研究获进展, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=246165310a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

Antiviral

2020-05-29

1249857fm39暂无昵称 (审核中...)

前往app查看评论内容

#Antiviral#

Antiviral Res：寨卡病毒基因工程疫苗研究新进展

2018-11-13

1249857fm39暂无昵称 (审核中...)

前往app查看评论内容

#Antiviral#

Antiviral Res：我国在单纯疱疹病毒中和抗体的研究中取得重要进展

2017-12-12

1249857fm39暂无昵称 (审核中...)

前往app查看评论内容

#Antiviral#

Antiviral Res：欧洲和欧亚国家的丙肝诊断和治疗的可用性

2018-08-01

1249857fm39暂无昵称 (审核中...)

前往app查看评论内容

#Antiviral#

Antiviral Res：在哺乳动物和植物细胞中产生的一个新的嵌合的HBV S/preS1抗原会引起比标准的疫苗成分S蛋白质更强的体液和细胞免疫反应

2017-10-06

1249857fm39暂无昵称 (审核中...)

前往app查看评论内容

#Antiviral#

Antiviral Res：中山大学曹永长教授研究团队发表H7N9流感病毒广谱疫苗研究进展

2017-12-16

1249857fm39暂无昵称 (审核中...)

前往app查看评论内容

#Antiviral#

Antiviral Res：T-705抑制剂可成功治疗早期埃博拉病毒感染

2015-10-16

1249857fm39暂无昵称 (审核中...)

前往app查看评论内容

#Antiviral#

Antiviral Res：拉沙热研究新机遇

2015-02-23

1249857fm39暂无昵称 (审核中...)

前往app查看评论内容

#Antiviral#

Antiviral Res：王建华等III型干扰素IFNλ抗HIV-1研究获进展

2012-07-22

科室
- - 订阅+
  - 更多科室
工具
服务